🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.790
-0.081 (-2.82%)
At close: Nov 19, 2026, 4:00 PM EST
2.400
-0.390 (-13.98%)
Pre-market: Nov 20, 2026, 4:59 AM EST

SNTI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.070.02-2.564.292.76
Revenue Growth
----40.25%55.23%387.81%
Cost of Revenue
7.7637.5934.3632.1528.1521.96
Gross Profit
-7.69-37.56-34.36-29.59-23.86-19.2
Selling, General & Admin
19.3320.7419.9234.8538.2321.25
Operating Expenses
38.4520.7419.9234.8538.2321.25
Operating Income
-46.13-58.3-54.28-64.44-62.08-40.45
Interest & Investment Income
0.30.930.952.861.70.01
Other Non Operating Income (Expenses)
0.980.9918.073.3-0.03-0.12
EBT Excluding Unusual Items
-44.85-56.39-35.26-58.28-60.42-40.56
Asset Writedown
-5.05-5.05-0.31-25.96--0.02
Other Unusual Items
6.88--17.220.8310.75-14.74
Pretax Income
-43.02-61.44-52.79-83.41-49.67-55.32
Earnings From Continuing Operations
-43.02-61.44-52.79-83.41-49.67-55.32
Earnings From Discontinued Operations
---12.35-8.55-
Net Income
-43.02-61.44-52.79-71.06-58.21-55.32
Preferred Dividends & Other Adjustments
--2.52---
Net Income to Common
-43.02-61.44-55.31-71.06-58.21-55.32
Net Income Growth
------
Shares Outstanding (Basic)
301000-
Shares Outstanding (Diluted)
301000-
Shares Change
5854.75%389.20%3.58%69.93%88.35%-
EPS (Basic)
-1.42-90.18-397.15-528.48-735.68-
EPS (Diluted)
-1.43-90.18-397.15-528.48-735.68-
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-35.33-43.64-41.42-64.43-76.27-40.18
Free Cash Flow Per Share
-1.17-64.05-297.43-479.20-963.93-
Operating Margin
-62343.24%-265018.18%--2516.28%-1448.53%-1464.90%
Profit Margin
-58140.54%-279263.64%--2774.62%-1358.14%-2003.59%
Free Cash Flow Margin
-47745.95%-198363.64%--2515.93%-1779.51%-1455.20%
EBITDA
-43.24-54.67-50.44-60.88-60.69-39.68
D&A For EBITDA
2.93.643.843.561.40.77
EBIT
-46.13-58.3-54.28-64.44-62.08-40.45
Revenue as Reported
---2.564.292.76
SEC Filings: 10-K · 10-Q